Abstract:Cortex Lycii, the root bark of Lycium chinense Mill. or Lycium barbarum L., is a frequently used traditional Chinese medicine. Phytochemical studies have shown that phenolic amides are not only characteristic compounds but also abundant ones in this plant. In the present study, an effective method was developed for structural characterization of phenolic amides from Cortex Lycii by ultra-high performance liquid chromatography coupled with linear ion trap Orbitrap tandem mass spectrometry. The fragmentation of 14 compounds including six cinnamic acid amides, six neolignanamides, and two lignanamides were studied systematically for the first time. It was found that, in the positive ion mode, neutral loss of the tyramide moiety (137 Da) or N-(4-aminobutyl)acetamide moiety (130 Da) were characteristic for these compounds. At least 54 phenolic amides were detected in the extract and 48 of them were characterized, among which 14 known compounds were identified unambiguously by comparing the retention time and mass spectra with those of reference compounds, and 34 components were tentatively identified based on the fragmentation patterns, exact mass, UV spectra, as well as retention time. Fifteen compounds were characterized as potential new ones. Additionally, the developed method was applied to analyze eight batches of samples collected from the northwest of China, and it was found that cinnamic acid amides were the main type of phenolic amides in Cortex Lycii. In conclusion, the identification of these chemicals provided essential data for further phytochemical studies, metabolites identification, and the quality control of Cortex Lycii.

The Anticancer Activities Phenolic Amides from the Stem of Lycium Barbarum

Bioactive Triterpenoid Saponins and Phenolic Compounds Against Glioma Cells

Bioactive Phenolics and Terpenoids from Manglietia Insignis.

Three new phenolic compounds from the lichen Thamnolia vermicularis and their antiproliferative effects in prostate cancer cells

Design, Syntheses and Biological Evaluation of Natural Product Aiphanol Derivatives and Analogues: Discovery of Potent Anticancer Agents

Biphenyl-type neolignans from stem bark of Magnolia officinalis with potential anti-tumor activity

Bioactive phenylpropanoid derivatives from the fruits of Lycium ruthenicum Murr

Neolignanamides, Lignanamides, and Other Phenolic Compounds from the Root Bark of Lycium Chinense

Lycibarbarines A–C, Three Tetrahydroquinoline Alkaloids Possessing a Spiro-Heterocycle Moiety from the Fruits of Lycium barbarum

A New Natural Compound with Cytotoxic Activity from Tripterygium Hypoglaucum

Four new diastereoisomeric neolignan glycosides from the root bark of Lycium chinense Miller. And their α -glucosidase inhibitory activity

Characterization and Profiling of Phenolic Amides from Cortex Lycii by Ultra-High Performance Liquid Chromatography Coupled with LTQ-Orbitrap Mass Spectrometry.

A new phenolic glycoside from the stem of Dendrobium nobile

Prenylated sulfonyl amides from the leaves of Glycosmis pentaphylla and their potential anti-proliferative and anti-inflammatory activities

Dimeric guaianolides and sesquiterpenoids from Artemisia anomala.

Cytotoxic Diterpenoids from the Bark of Pseudolarix Kaempferi and Their Structure-Activity Relationships

Structural Modification and Inhibitory Activity on Tumor Cell Proliferation of Novel Diaryl-β-lactam Compounds As Tubulin Aggregation Inhibitors

Novel Lycorine Derivatives As Anticancer Agents: Synthesis and in Vitro Biological Evaluation

Four new steroidal glycosides from Lilium lancifolium Thunb. and their antitumor activity

Preparation of Lycium barbarum Active Glycopeptide and Investigation of Its Apoptotic Effects on Melanoma

New Phenolic Glycosides and Lignans from the Roots of Lilium Dauricum